Clinical Trial Update: An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris [Phase 1]

View source ↗

Summary

An extension Phase 1 trial evaluating dapsone for acne vulgaris has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• ACZONE (DAPSONE)
• DAPSONE (dapsone)

Snippet

Sponsor: Allergan | Conditions: Acne Vulgaris | Phase 1 | Status: WITHDRAWN